You may not be able to see nasal polyps, but that doesn’t mean you can’t sense their constant presence. In fact, more than half of people who have the condition say that reducing or eliminating their ...

Nasal polyp surgery removes noncancerous growths from your nasal and sinus passageways. In the weeks following surgery, you may notice slight bleeding from your nose and crusts. It’s common for polyps ...

If you feel like spring allergy season never ends or your colds always turn into sinus infections, you may have the potential to develop nasal polyps. Although you may not know they are there, nasal ...

Does your nose seem to always be stuffed up? Do you have loss of taste or smell? Do you get frequent sinus infections? If so, you may have nasal polyps. Which raises the question: What exactly are ...

Nasal polyps are soft growths that can develop in your nose as a result of long-term swelling — from colds, allergies, and other conditions — in your nasal passages. They are more common in people who ...

Constantly congested? The culprit could be nasal polyps, noncancerous growths that leave your nose stuffed and your sense of smell stymied. We asked a top ear, nose and throat specialist to tell us ...

Please provide your email address to receive an email when new articles are posted on . In fact, many patients may self-medicate with over-the-counter allergy medications for months or years without ...

Nasal polyps often develop in conjunction with a prolonged sinus infection, leading to chronic rhinosinusitis with nasal polyps. Chronic rhinosinusitis with nasal polyps is treated with nasally ...

Patients with comorbid chronic rhinosinusitis (CRS) with nasal polyps and asthma reported significant reductions in endoscopic sinus score and severity, as well as decreased dosage of oral steroids ...

A study of the nasal microbiome helped researchers predict recurrent polyps in chronic rhinosinusitis patients with more than 90% accuracy, based on data from 85 individuals. Chronic rhinosinusitis ...

An international collaboration of researchers, sponsored by GSK and working on behalf of the ANCHOR-1 and ANCHOR-2 trial investigators, conducted two Phase III clinical trials to evaluate depemokimab, ...